ACR适宜性标准2026更新:子宫内膜癌治疗前评估与随访
该指南由美国放射学会发布,针对已确诊子宫内膜癌患者的治疗前评估、监测及疑似复发评估给出影像推荐。盆腔MRI(平扫+增强)通常适用于评估局部肿瘤浸润;侵袭性组织学类型或怀疑转移时,胸部+腹部+盆腔增强CT和FDG-PET/CT通常适用;无症状低-中危治疗后患者常规影像监测通常不适用,而疑似复发时上述三种检查通常适用。
要点
- 盆腔MRI(平扫+增强)是评估子宫内膜癌局部浸润范围的通常适用方法。
- 侵袭性组织学类型或怀疑转移时,增强CT(胸腹盆)和FDG-PET/CT通常适用。
- 无症状低-中危治疗后患者,常规影像监测通常不适用;疑似复发时三种影像均通常适用。
诊断标准与关键数值
- 盆腔MRI(平扫+增强)通常适用于各组织学亚型和分级的局部肿瘤浸润评估。
- 侵袭性组织学类型或怀疑转移时,增强CT(胸腹盆)和FDG-PET/CT通常适用于评估淋巴结和远处转移。
- 无症状低-中危治疗后患者常规影像监测通常不适用;部分无症状高危患者CT可能适用。
- 疑似复发时,盆腔MRI、增强CT(胸腹盆)和FDG-PET/CT通常适用。
临床应用与阅片要点
- 治疗前应首选盆腔MRI(平扫+增强)评估局部浸润范围。
- 对侵袭性组织学类型或怀疑转移者,应加做增强CT(胸腹盆)和/或FDG-PET/CT。
- 避免对无症状低-中危治疗后患者进行常规影像监测。
- 疑似复发时,可选用盆腔MRI、增强CT或FDG-PET/CT进行评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Endometrial cancer is the most common gynecologic malignancy in the United States, and accurate pretreatment evaluation is essential for risk stratification, treatment planning, and detection of recurrent disease. This evidence-based review summarizes imaging recommendations for patients with established endometrial cancer undergoing pretreatment assessment, surveillance, or evaluation for suspected recurrence. MRI pelvis without and with intravenous contrast is usually appropriate for assessment of local tumor extension across histologic subtypes and grades. For aggressive histologic tumor types, or when metastatic disease is suspected, CT chest, abdomen, and pelvis with intravenous contrast and FDG-PET/CT are usually appropriate for evaluation of nodal and distant metastases. Routine imaging surveillance is usually not appropriate for asymptomatic patients with treated low- or intermediate-risk disease, whereas CT may be appropriate in selected asymptomatic high-risk patients. MRI pelvis, CT chest, abdomen, and pelvis, and FDG-PET/CT are usually appropriate for suspected recurrence. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision process support the systematic analysis of the medical literature from peer reviewed journals. Established methodology principles such as Grading of Recommendations Assessment, Development, and Evaluation or GRADE are adapted to evaluate the evidence. The RAND/UCLA Appropriateness Method User Manual provides the methodology to determine the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where peer reviewed literature is lacking or equivocal, experts may be the primary evidentiary source available to formulate a recommendation.
引用
- Sertic M, Venkatesan AM, Suarez-Weiss K, et al. ACR Appropriateness Criteria® Pretreatment Evaluation and Follow-Up of Endometrial Cancer: 2026 Update. J Am Coll Radiol. 2026. PMID: 42955038. doi:10.1016/j.jacr.2026.09.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。